{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:48:43Z","timestamp":1791413323801,"version":"4.3.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["HHSN272201000040I"],"award-info":[{"award-number":["HHSN272201000040I"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["HHSN27200007"],"award-info":[{"award-number":["HHSN27200007"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.antiviral.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T05:25:07Z","timestamp":1466918707000},"page":"210-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Antiviral effect of ranpirnase against Ebola virus"],"prefix":"10.1016","volume":"132","author":[{"given":"Thomas","family":"Hodge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Brasel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Freiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Squiquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Sulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra J.","family":"Taxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.06.009_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2165\/00126839-200708020-00007","article-title":"Ranpirnase: amphibian ribonuclease A, P-30 protein-alfacell","volume":"8","author":"Alfacell","year":"2007","journal-title":"Drugs R&D"},{"key":"10.1016\/j.antiviral.2016.06.009_bib2","first-page":"663","article-title":"Onconase, an anti-tumor ribonuclease suppresses intracellular oxidative stress","volume":"31","author":"Ardelt","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.antiviral.2016.06.009_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9258(18)52427-3","article-title":"Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases","volume":"266","author":"Ardelt","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.06.009_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/138920108784567245","article-title":"Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes","volume":"9","author":"Ardelt","year":"2008","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.antiviral.2016.06.009_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A\u00a0mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.009_bib6","series-title":"Ebola Outbreak in West Africa \u2013 Case Counts","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"10.1016\/j.antiviral.2016.06.009_bib7","first-page":"1","article-title":"Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control","author":"Chughtai","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.antiviral.2016.06.009_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/07357900500283143","article-title":"Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase","volume":"23","author":"Costanzi","year":"2005","journal-title":"Cancer investig."},{"key":"10.1016\/j.antiviral.2016.06.009_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA persistence in semen of Ebola virus disease survivors - preliminary report","author":"Deen","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.06.009_bib10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.06.009_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/excr.2002.5568","article-title":"Activation of caspases and serine proteases during apoptosis induced by onconase (Ranpirnase)","volume":"278","author":"Grabarek","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.antiviral.2016.06.009_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/nar\/gkg163","article-title":"Ribonuclease inhibitor as an intracellular sentry","volume":"31","author":"Haigis","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.06.009_bib13","first-page":"841","article-title":"Mild hyperthermia predisposes tumor cells to undergo apoptosis upon treatment with onconase","volume":"30","author":"Halicka","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.antiviral.2016.06.009_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrg3765","article-title":"Identification and consequences of miRNA-target interactions\u2013beyond repression of gene expression","volume":"15","author":"Hausser","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2016.06.009_bib15","first-page":"53","article-title":"Ribonucleases as novel chemotherapeutics : the ranpirnase example","volume":"22","author":"Lee","year":"2008","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"10.1016\/j.antiviral.2016.06.009_bib16","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1073\/pnas.95.18.10407","article-title":"Ribonuclease A variants with potent cytotoxic activity","volume":"95","author":"Leland","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.06.009_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/bbrc.1994.2439","article-title":"Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease","volume":"204","author":"Lin","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.06.009_bib18","first-page":"58","article-title":"Recurrence and reinfection-a new paradigm for the management of Ebola virus disease","volume":"43","author":"MacIntyre","year":"2016","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.06.009_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2006.09.018","article-title":"Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells","volume":"250","author":"Michaelis","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.antiviral.2016.06.009_bib20","first-page":"57","article-title":"Phase-I human clinical-trial of onconase(r) (p-30 protein) administered intravenously on a weekly schedule in cancer-patients with solid tumors","volume":"3","author":"Mikulski","year":"1993","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.antiviral.2016.06.009_bib21","first-page":"633","article-title":"Enhanced in\u00a0vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor","volume":"13","author":"Mikulski","year":"1998","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.antiviral.2016.06.009_bib22","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1021\/bi000415x","article-title":"Onconase: an unusually stable protein","volume":"39","author":"Notomista","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2016.06.009_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/BTT.S2383","article-title":"Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma","volume":"2","author":"Porta","year":"2008","journal-title":"Biol. Targets Ther."},{"key":"10.1016\/j.antiviral.2016.06.009_bib24","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1242\/jcs.03427","article-title":"Intracellular pathway of Onconase that enables its delivery to the cytosol","volume":"120","author":"Rodriguez","year":"2007","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.antiviral.2016.06.009_bib25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jnci\/88.11.747","article-title":"Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease","volume":"88","author":"Rybak","year":"1996","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.antiviral.2016.06.009_bib26","first-page":"1067","article-title":"Effect of Onconase on double-stranded RNA in\u00a0vitro","volume":"29","author":"Saxena","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.antiviral.2016.06.009_bib27","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1074\/jbc.271.34.20783","article-title":"Inhibition of HIV-1 production and selective degradation of viral RNA by an amphibian ribonuclease","volume":"271","author":"Saxena","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.06.009_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14712590802631862","article-title":"Targeted therapeutic RNases (ImmunoRNases)","volume":"9","author":"Schirrmann","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.antiviral.2016.06.009_bib29","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1074\/jbc.M504488200","article-title":"Transfer RNA cleavages by onconase reveal unusual cleavage sites","volume":"281","author":"Suhasini","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.06.009_bib30","first-page":"4180","article-title":"Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamily","volume":"56","author":"Vasandani","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2016.06.009_bib31","doi-asserted-by":"crossref","first-page":"10686","DOI":"10.1016\/S0021-9258(18)82252-9","article-title":"A\u00a0cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity","volume":"268","author":"Wu","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.06.009_bib32","doi-asserted-by":"crossref","first-page":"17476","DOI":"10.1074\/jbc.270.29.17476","article-title":"A\u00a0study of the intracellular routing of cytotoxic ribonucleases","volume":"270","author":"Wu","year":"1995","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T01:44:04Z","timestamp":1656726244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216301516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":32,"alternative-id":["S0166354216301516"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.06.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral effect of ranpirnase against Ebola virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}